Neola Medical EN
  • Lung Monitoring
  • The technology
  • Our Studies
  • About Us
  • Career
  • Investors
    • To invest in Neola Medical
    • Stock information
    • Annual General Meetings
    • Corporate governance
    • Certified Adviser
    • Rights Issue 2022
    • Investor Relations
    • IPO 2020
    • Presentations
    • Press releases
    • Reports and Financial Calendar
    • Warrants of series TO1
  • News
    • Press releases
    • Articles and posts
  • SE
Select Page

The business newspaper Rapidus draws attention to Neola Medical’s support from Stanford

Oct 24, 2023

In today’s Rapidus news, CEO Hanna Sjöström talks about the importance for Neola Medical being selected as a Stanford Impact1 company.

Read the article in English here: Rapidus – A Lund city-based company is supported by Stanford

Read the article (Swedish) here: Rapidus – Lundabolag får stöd av Stanford

About Neola Medical

Neola Medical AB (publ) is revolutionizing neonatal intensive care with Neola®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. Neola® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

Sweden, HQ

Neola Medical AB
Scheelevägen 27
223 63 Lund
info@neolamedical.com

USA

Neola Medical AB
Nordic Innovation House
470 Ramona Street PMB
Palo Alto CA 94301-1707
info@neolamedical.com